What type of study is this?

September 10, 2025Health Affairs

Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations

View Full Paper

Ask AI

Bookmark

Authors

Framework advocates for improved price negotiations in CMS, integrating health technology assessment and stakeholder engagement.

Stakeholder engagement improves transparency and inclusivity in CMS drug price negotiations.
The new framework includes assessing value, selecting alternatives, and utilizing an independent advisory committee.
Recent negotiations covered ten drugs, with prices set to take effect on January 1, 2026.
The approach is rooted in best practices of health technology assessment for fair drug pricing.

Ollendorf et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark